We are currently restructuring our databases, so be advised that the FCPAC database is updated only through July 30, 2025.

Processing your request


please wait...

Investigations Dataset

 

Investigation Name:    Investigation into Stryker's Activities in Undisclosed Countries

Trend:    None

Type of investigation:    Internal, SEC, DOJ

Other Agencies Investigating/Assisting with SEC/DOJ Investigation:    Unknown

Whistleblower:    Unknown

Summary

Stryker Corporation is a Michigan corporation that manufactures and distributes medical devices and products in more than 100 countries around the world. The company's common stock is registed with the SEC and traded on the New York Stock Exchange.

In its 10-Q filed on May 2, 2023, Stryker disclosed that it was currently investigating whether certain business activities in a foreign country violated the FCPA. The company said it had engaged outside counsel to conduct the investigation, and following contact from the DOJ and SEC, it said it was cooperating with both agencies.

In its 10-Q filed on May 2, 2025, Stryker disclosed that the DOJ had informed the company on April 1 that it was closing its investigation with no further action.

The SEC investigation appears to be ongoing.

Protected Content


Please Log In or Sign Up for a free account to access restricted features of the Clearinghouse website, including the Advanced Search form and the full case pages.

When you sign up, you will have the option to save your search queries performed on the Advanced Search form.